Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Fazi

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Hematological Oncology|February 14, 2008
Heterogeneity in the therapeutic approach to relapsed elderly patients with acute myeloid leukaemia: a survey from the Gruppo Italiano Malattie Ematologiche dell' Adulto (GIMEMA) Acute Leukaemia Working PartyFelicetto Ferrara, Paola Fazi, Adriano Venditti, et al.
JMIR Research Protocols|April 23, 2021
The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational StudyFabio Efficace, Massimo Breccia, Paola Fazi, et al.
Proceedings. AMIA Symposium|December 5, 2002
WITH: a system to write clinical trials using XML and RDBMSPaola Fazi, Daniela Luzi, Mariarosaria Manco, et al.
Eclinicalmedicine|July 23, 2025
Exploring patient-reported outcomes and morbidity burden of patients with VEXAS syndrome: a scoping reviewFabio Efficace, Daniela Krepper, Francesco Sparano, et al.
Contemporary Clinical Trials Communications|September 15, 2022
Regulation 536/2014 and its beneficial impacts on academic clinical research in Italy. Closing the loopAlessandra Mancino, Enrico Crea, Monica Messina, et al.
BMJ Supportive & Palliative Care|May 9, 2024
Financial toxicity and health-related quality of life in long-term survivors of acute promyelocytic leukaemiaFrancesco Sparano, Maria Teresa Voso, Adriano Venditti, et al.
Future Oncology (London, England)|January 18, 2023
ENABLE: treatment combination including decitabine and venetoclax in acute myeloid leukemia secondary to myeloproliferative neoplasmsFrancesco Mannelli, Paola Guglielmelli, Paola Fazi, et al.
Haematologica|March 9, 2004
GIMEMA ALL - Rescue 97: a salvage strategy for primary refractory or relapsed adult acute lymphoblastic leukemiaAndrea Camera, Luciana Annino, Federico Chiurazzi, et al.
British Journal of Haematology|July 5, 2020
The COVID-19 pandemic and management of GIMEMA clinical trials: changes and challengesAlfonso Piciocchi, Monica Messina, Stefano Soddu, et al.
Haematologica|March 9, 2004
Methylenetetrahydrofolate reductase genotypes do not play a role in acute lymphoblastic leukemia pathogenesis in the Italian populationPatrizia Chiusolo, Giovanni Reddiconto, Giuseppe Cimino, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Hematological Oncology|February 14, 2008
Heterogeneity in the therapeutic approach to relapsed elderly patients with acute myeloid leukaemia: a survey from the Gruppo Italiano Malattie Ematologiche dell' Adulto (GIMEMA) Acute Leukaemia Working PartyFelicetto Ferrara, Paola Fazi, Adriano Venditti, et al.
JMIR Research Protocols|April 23, 2021
The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational StudyFabio Efficace, Massimo Breccia, Paola Fazi, et al.
Proceedings. AMIA Symposium|December 5, 2002
WITH: a system to write clinical trials using XML and RDBMSPaola Fazi, Daniela Luzi, Mariarosaria Manco, et al.
Eclinicalmedicine|July 23, 2025
Exploring patient-reported outcomes and morbidity burden of patients with VEXAS syndrome: a scoping reviewFabio Efficace, Daniela Krepper, Francesco Sparano, et al.
Contemporary Clinical Trials Communications|September 15, 2022
Regulation 536/2014 and its beneficial impacts on academic clinical research in Italy. Closing the loopAlessandra Mancino, Enrico Crea, Monica Messina, et al.
BMJ Supportive & Palliative Care|May 9, 2024
Financial toxicity and health-related quality of life in long-term survivors of acute promyelocytic leukaemiaFrancesco Sparano, Maria Teresa Voso, Adriano Venditti, et al.
Future Oncology (London, England)|January 18, 2023
ENABLE: treatment combination including decitabine and venetoclax in acute myeloid leukemia secondary to myeloproliferative neoplasmsFrancesco Mannelli, Paola Guglielmelli, Paola Fazi, et al.
Haematologica|March 9, 2004
GIMEMA ALL - Rescue 97: a salvage strategy for primary refractory or relapsed adult acute lymphoblastic leukemiaAndrea Camera, Luciana Annino, Federico Chiurazzi, et al.
British Journal of Haematology|July 5, 2020
The COVID-19 pandemic and management of GIMEMA clinical trials: changes and challengesAlfonso Piciocchi, Monica Messina, Stefano Soddu, et al.
Haematologica|March 9, 2004
Methylenetetrahydrofolate reductase genotypes do not play a role in acute lymphoblastic leukemia pathogenesis in the Italian populationPatrizia Chiusolo, Giovanni Reddiconto, Giuseppe Cimino, et al.
Pageof 10